Concomitant Treatment of Tuberculosis and Hepatitis C Virus in Coinfected Patients Using Serum Drug Concentration Monitoring

BACKGROUND: Concern for drug-drug interactions leading to treatment failure and drug-resistant strains have discouraged clinicians from attempting concomitant treatment of hepatitis C virus (HCV) and tuberculosis (TB). Increased metabolism of direct-acting antivirals (DAAs) by rifamycins has hindere...

Descripción completa

Detalles Bibliográficos
Autores principales: Ashkin, Alex, Alexis, Afe, Ninneman, Megan, Tresgallo, Rene Rico, Ashkin, David, Peloquin, Charles A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296065/
https://www.ncbi.nlm.nih.gov/pubmed/37383253
http://dx.doi.org/10.1093/ofid/ofad237

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296065/
https://www.ncbi.nlm.nih.gov/pubmed/37383253
http://dx.doi.org/10.1093/ofid/ofad237

Ejemplares similares